Discovery Labs and FDA to Meet On September 29, 2009 to Discuss Potential Path for SURFAXIN Approval Sep 11, 2009
Source: Discovery Laboratories, Inc. ... Sept. 10, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq: - ) has received written notification from the U.S. Food and Drug Administration (FDA) that a meeting has been scheduled for September 29, 2009 ... Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. (Primezone Releases)
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO Aug 14, 2009
Source: Discovery Laboratories, Inc. ... Aug. 13, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq: - ), a biotechnology company developing its proprietary KL4 surfactant technology to improve respiratory critical care medicine, today announced the resignation of President and Chief Executive Officer Robert J. Capetola, Ph ... Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. (Primezone Releases)
Discovery Laboratories drug faces significant hurdle Jul 3, 2009
Discovery Laboratories drug faces significant hurdle - Philadelphia Business Journal ... Discovery Laboratories drug faces significant hurdle. (Philadelphia Business Journal, PA)
Discovery Faces Further FDA Delays on Surfaxin Jul 2, 2009
Discovery Laboratories faces further FDA delays on review of respiratory drug candidate ... Discovery Laboratories Inc. said Wednesday the Food and Drug Administration will apply a new standard to the company's respiratory drug candidate application, likely further holding up approval ... Shares of Discovery Laboratories fell 12 cents, or 11 percent, to 94 cents in after-hours trading. (ABC News -- Wire)
Drilling Results for Commerce Resources Eldor Tantalum, Niobium, Rare Earth Project in Quebec Jun 3, 2009
Approximately 4% of all samples have been sent to an alternate laboratory (Global Discovery Laboratories, Vancouver, BC) for check assaying of niobium, tantalum, phosphate and uranium. Several samples have also been sent to Activation Laboratories located in Ancaster, ON and results are pending. (Canada Newswire)
Discovery Labs Announces Completion of $11.3 Million Registered Direct Offering May 14, 2009
Press Release Source: Discovery Laboratories, Inc. ... May 13, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (NasdaqGM: - ) today announced that it has completed its previously announced registered direct offering of 14 million shares of its common stock and warrants for 7 million shares of common stock ... Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. (Primezone Releases)
Discovery Laboratories to raise $11M May 9, 2009
for free extra services. Subscribe to Philadelphia Business Journal. (Philadelphia Business Journal, PA)
Oral Delivery System For RNAi Therapeutics May 6, 2009
ScienceDaily (May 5, 2009) Researchers at the University of Massachusetts Medical School (UMMS) report April 28 on a novel approach to the delivery of small bits of genetic material in order to silence genes using "RNA interference" and in the process, discovered a potent method of suppressing inflammation in mice similar to what occurs in a range of human diseases. In the April 30, 2009 issue of the journal Nature, Professor Michael P. Czech, PhD, and colleagues in the Program in Molecular... (Science Daily)
Pancreatic cancer therapy 'hope' Apr 19, 2009
CRT's discovery laboratories director Dr Hamish Ryder said the team focused on pancreatic and lung cancer tumours because they are cancers with a "significant unmet medical need". Dr Sushovan Guha, who leads the laboratory at MD Anderson Cancer Center and collaborated in the project, added he was optimistic about the drug's potential. (BBC News -- UK)
Discovery Labs Provides Update Regarding Surfactant Aerosol Generation Technology Apr 14, 2009
Press Release Source: Discovery Laboratories, Inc. ... April 14, 2009 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (NasdaqGM: - ) today announces that it continues to make significant progress in the development of its proprietary Capillary Aerosolization Technology ... Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Replacement Therapies (SRT) for respiratory diseases. (Primezone Releases)
Discovery Labs' viability questioned Mar 14, 2009
Auditors question viability of Discovery Laboratories - Philadelphia Business Journal ... Auditors question viability of Discovery Laboratories. (Philadelphia Business Journal, PA)
